CELL SURFACE CD20 ANTIGEN EXPRESSION ANALYSIS IN CHRONIC LYMPHOCYTIC LEUKEMIA

被引：0
|
作者：
Giordano, A. [1 ]
Curci, P. [1 ]
Rizzi, R. [1 ]
Perrone, T. [1 ]
Delia, M. [1 ]
Mestice, A. [1 ]
Nardelli, G. [1 ]
Di Tardo, I. [1 ]
Specchia, G. [1 ]
机构：
[1] Azienda Osped Univ Policlin Consorziale Bari, Hematol, Bari, Italy
来源：
HAEMATOLOGICA | 2013年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
B1328
引用
收藏
页码：541 / 541
页数：1
相关论文
共 50 条
  • [31] Expression of CD20 in B Cell Precursor Acute Lymphoblastic Leukemia
    Kumar, Jeevan
    Khan, Afaq Ahmad
    Saraf, Amrita
    Bhargava, Manorama
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2014, 30 (01) : 16 - 18
  • [32] Expression of CD20 in B Cell Precursor Acute Lymphoblastic Leukemia
    Jeevan Kumar
    Afaq Ahmad Khan
    Amrita Saraf
    Manorama Bhargava
    Indian Journal of Hematology and Blood Transfusion, 2014, 30 : 16 - 18
  • [33] Prognostic significance of CD38 and CD20 expression in chronic lymphocytic leukemia (CLL) as assessed by quantitative flow cytometry.
    Hsi, E
    Kopecky, KJ
    Appelbaum, FR
    Boldt, DH
    Loftus, M
    Frey, T
    Hussein, MA
    BLOOD, 2001, 98 (11) : 357A - 357A
  • [34] Utility of CD200 expression and CD20 antibody binding capacity in differentiating chronic lymphocytic leukemia from other chronic lymphoproliferative disorders
    Poongodi, R.
    Varma, Neelam
    Naseem, Shano
    Parveen, Bose
    Varma, Subhash
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (01) : 50 - 57
  • [35] Utility of CD200 Expression and CD20 Antibody Binding Capacity in Differentiating Chronic Lymphocytic Leukemia from Other Chronic Lymphoproliferative Disorders
    Naseem, Shano
    Poongodi, R.
    Varma, Neelam
    Malhotra, Pankaj
    Varma, Subhash
    BLOOD, 2015, 126 (23)
  • [36] Leukemia Cell Surface Antigen Modulation Induced By Dual CD19/CD20 Chimeric Antigen Receptor (CAR)-T Cells
    Schneider, Dina
    Xiong, Ying
    Wu, Darong
    Nolle, Volker
    Schmitz, Sarah
    Kaiser, Andrew
    Dropulic, Boro
    Orentas, Rimas
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2017, 23 (03) : S209 - S210
  • [37] Prognostic value of CD20 antigen mediated immune checkpoint inhibition in patients with acute or chronic lymphocytic leukemia A protocol for systematic review
    Mkhwanazi, Zekhethelo A.
    Mfusi, Snenhlanhla A.
    Nkambule, Bongani B.
    MEDICINE, 2022, 101 (07) : E28868
  • [38] Mutations in the 3′ untranslated region of NOTCH1 are associated with low CD20 expression levels in chronic lymphocytic leukemia
    Bittolo, Tamara
    Pozzo, Federico
    Bomben, Riccardo
    D'Agaro, Tiziana
    Bravin, Vanessa
    Bulian, Pietro
    Rossi, Francesca Maria
    Zucchetto, Antonella
    Degan, Massimo
    Macor, Paolo
    D'Arena, Giovanni
    Chiarenza, Annalisa
    Zaja, Francesco
    Pozzato, Gabriele
    Di Raimondo, Francesco
    Rossi, Davide
    Gaidano, Gianluca
    Del Poeta, Giovanni
    Gattei, Valter
    Dal Bo, Michele
    HAEMATOLOGICA, 2017, 102 (08) : E305 - E309
  • [39] Fractionated subcutaneous rituximab is well-tolerated and preserves CD20 expression on tumor cells in patients with chronic lymphocytic leukemia
    Aue, Georg
    Lindorfer, Margaret A.
    Beum, Paul V.
    Pawluczkowycz, Andrew W.
    Vire, Berengere
    Hughes, Thomas
    Taylor, Ronald P.
    Wiestner, Adrian
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 (02): : 329 - 332
  • [40] B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA WITH ABERRANT EXPRESSION OF CD8 ANTIGEN
    PORWIT, A
    BORGONOVO, L
    OSBY, E
    LENKEI, R
    SMITH, CIE
    HAMMARSTROM, L
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1987, 39 (04) : 311 - 317
12345